IntermediateImmune SupportLongevity

Thymosin Alpha-1

Tα1 · Thymalfasin · 28-Amino Acid Immunopeptide

Thymosin Alpha-1 is one of the most extensively studied immunomodulatory peptides in the world — approved in over 35 countries for viral hepatitis, cancer adjunct therapy, and immune deficiency. It orchestrates T-cell maturation, NK cell activity, and innate immune signaling, making it a foundational protocol for immune optimization and resilience.

Researched Wellness Applications

✓ T-cell activation & immune modulation

✓ Chronic viral & infection support

✓ Post-illness immune recovery

✓ Cancer adjunct & chemotherapy support

✓ Long COVID immune dysregulation

Assessment Options

$299

No subscription required · Physician reviewed

Start Physician Review →

Physician review required · Ships in 48h after approval · All 50 states

Split payments available with affirm — 0% interest options

What Is It?

Thymosin Alpha-1 explained simply

Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide naturally occurring in the thymus gland — the organ responsible for T-cell education and immune system training. It was first isolated in the 1970s by Dr. Allan Goldstein and has since become one of the most extensively studied immunopeptides in clinical medicine, approved in over 35 countries under the trade name Zadaxin.

Tα1 works by enhancing the maturation and activity of CD4+ and CD8+ T-cells, stimulating natural killer (NK) cell function, promoting dendritic cell activation, and upregulating key cytokine signals including interferon-α and interleukin-2. The result is a more robust, coordinated immune response — without the overstimulation or autoimmune risk associated with non-targeted immune stimulants.

It has been particularly studied in the context of viral hepatitis, HIV, cancer immunotherapy, and more recently, post-COVID immune dysregulation and Long COVID. For wellness clients, Thymosin Alpha-1 is used as a proactive immune optimization tool and post-illness recovery protocol.

35+

Countries approved

Amino acids

Subcutaneous injection

Mechanism

How Thymosin Alpha-1 works

T-Cell Maturation & Activation

Tα1 acts on immature thymocytes to promote their maturation into functional CD4+ helper T-cells and CD8+ cytotoxic T-cells. It also enhances the activity of already-circulating T-cells, improving their ability to recognize and respond to both novel and chronic threats. This is its primary immunological mechanism and the basis for its use in viral hepatitis and cancer protocols globally.

NK Cell & Innate Immune Enhancement

Beyond T-cell effects, Tα1 enhances natural killer (NK) cell activity — the immune system's front-line surveillance cells that identify and destroy virally infected or malignant cells. It also stimulates dendritic cell function, which is critical for presenting antigens to T-cells and coordinating adaptive immune responses. These combined effects make it effective across both innate and adaptive immunity.

Long COVID & Post-Viral Immune Support

Emerging research has studied Thymosin Alpha-1 in the context of Long COVID and post-viral immune dysregulation — conditions characterized by persistent T-cell exhaustion, cytokine imbalance, and incomplete viral clearance. Several case series and clinical observations suggest Tα1 may help normalize immune function in these populations, though larger controlled trials are ongoing.

Administration

Thymosin Alpha-1 is administered via subcutaneous injection, typically on a twice-weekly or specific pulsed schedule determined by your BRAVO1 physician based on your immune history, goals, and current health status. Protocols for proactive immune optimization differ from those for active infection support. Do not self-administer any peptide protocol without physician oversight.

FAQ

Questions about Thymosin Alpha-1

Thymosin Alpha-1 (Zadaxin) is approved in over 35 countries for chronic hepatitis B, hepatitis C, cancer adjunct therapy, and immune deficiency conditions. It is not currently FDA-approved in the United States and is available through compounding pharmacies for physician-directed use. All BRAVO1 protocols are developed by licensed physicians and fulfilled through our licensed pharmacy partner.

Tα1 is appropriate for a range of clients: those with chronic infections or immune dysregulation, individuals recovering from illness or Long COVID, those undergoing cancer treatment (as adjunct support), and high-performance individuals using it proactively for immune resilience. Appropriateness is assessed through our physician review process.

No. Tα1 is an immunomodulator — it normalizes immune function rather than simply amplifying it. This is a key distinction from non-targeted immune stimulants. Clinical data across decades of international use has shown a favorable safety profile, with no increased risk of autoimmune conditions when used at appropriate doses under physician supervision.

All BRAVO1 orders ship within 48 hours of physician approval from our temperature-controlled facility. Delivery is available to all 50 states.

Ready to begin?

Start the physician review process for Thymosin Alpha-1. Ships within 48 hours of approval to all 50 states.

Start Physician Review →

Physician Reviewed

Ships to All 50 States

48-Hour Fulfillment

LegitScript Certified

Licensed Pharmacy Partner

Partner Pharmacy

PerfectRx

Phone(866) 866-6806

Emailinfo@perfectrx.com

Address5810 Long Prairie Rd
Flower Mound, TX 75028

Service Availability

United States

Serving all 50 states. Products are fulfilled through our licensed compounding pharmacy partner and shipped directly to patients following physician approval.

Provider Licensure Disclosures

Arora Health and Aesthetics · Dr. Sean Arora

Vermont

License 042.0016085-COMPExpires 11/31/2026

Rhode Island

License MD20370Expires 06/30/2026

Massachusetts

License 1018420Expires 07/20/2027